Literature DB >> 1789804

Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.

A R Folsom1, K K Wu, C E Davis, M G Conlan, P D Sorlie, M Szklo.   

Abstract

Recent prospective investigations have reported that higher plasma fibrinogen concentrations and higher factor VII coagulant activity are associated with greater risk of cardiovascular disease. To discover what characteristics may influence fibrinogen and factor VII, we analyzed data from the Atherosclerosis Risk in Communities Study obtained from over 12,000 men and women, aged 45-64 years, from four communities in December 1986 to June 1989. Fibrinogen was higher in blacks than whites and in women than men; in general, it increased with age, smoking, body size, diabetes, fasting serum insulin, LDL cholesterol, lipoprotein(a), leukocyte count, and menopause, and it decreased with ethanol intake, physical activity, HDL cholesterol, and female hormone use. Factor VII was higher in women than men and, in women, increased with age; in both sexes, it increased with body size, triglycerides, LDL cholesterol, and HDL cholesterol, and it decreased with ethanol intake. These findings indicate that elevations in fibrinogen and factor VII may be modifiable through appropriate lifestyle changes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1789804     DOI: 10.1016/0021-9150(91)90167-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  31 in total

Review 1.  The menopause and its treatment in perspective.

Authors:  F Al-Azzawi
Journal:  Postgrad Med J       Date:  2001-05       Impact factor: 2.401

2.  Potential explanations for the educational gradient in coronary heart disease: a population-based case-control study of Swedish women.

Authors:  S P Wamala; M A Mittleman; K Schenck-Gustafsson; K Orth-Gomér
Journal:  Am J Public Health       Date:  1999-03       Impact factor: 9.308

3.  Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors.

Authors:  E B Rimm; P Williams; K Fosher; M Criqui; M J Stampfer
Journal:  BMJ       Date:  1999-12-11

4.  Physical activity, physical fitness, blood pressure, and fibrinogen in the Northern Ireland health and activity survey.

Authors:  D MacAuley; E E McCrum; G Stott; A E Evans; B McRoberts; C A Boreham; K Sweeney; T R Trinick
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

Review 5.  The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women.

Authors:  B L Haddock; H P Marshak; J J Mason; G Blix
Journal:  Sports Med       Date:  2000-01       Impact factor: 11.136

Review 6.  Cardiovascular pharmacology of hormone replacement therapy.

Authors:  G M Rosano; G Panina
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

Review 7.  Cardiac rehabilitation past, present and future: an overview.

Authors:  Warner M Mampuya
Journal:  Cardiovasc Diagn Ther       Date:  2012-03

8.  Pleiotropic effects of n-6 and n-3 fatty acid-related genetic variants on circulating hemostatic variables.

Authors:  Lu-Chen Weng; Weihua Guan; Lyn M Steffen; James S Pankow; Nathan Pankratz; Ming-Huei Chen; Mary Cushman; Saonli Basu; Aaron R Folsom; Weihong Tang
Journal:  Thromb Res       Date:  2018-06-01       Impact factor: 3.944

9.  Idiopathic pulmonary thromboembolism in the course of intensive psychiatric inpatient care: case report and treatment guidelines.

Authors:  Shane J McInerney; Colm McDonald
Journal:  BMJ Case Rep       Date:  2012-09-07

Review 10.  Influence of fibrinogen on cardiovascular disease.

Authors:  W B Kannel
Journal:  Drugs       Date:  1997       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.